Copyright
©The Author(s) 2025.
World J Orthop. Jul 18, 2025; 16(7): 106281
Published online Jul 18, 2025. doi: 10.5312/wjo.v16.i7.106281
Published online Jul 18, 2025. doi: 10.5312/wjo.v16.i7.106281
Table 5 Cumulative percent revision rates across the American Joint Replacement Registry, Australian Orthopaedic Association National Joint Replacement Registry, and United Kingdom National Joint Registry
Registry | PS | CR/minimally stabilized/unconstrained | ||
1 year, rate (95%CI) | 3 years, rate (95%CI) | 1 year, rate (95%CI) | 3 years, rate (95%CI) | |
AJRR (Truliant data) | 0.82 (0.51-1.13) | 1.76 (1.09- 2.43) | 0.18 (0-0.44) | 0.39 (0-0.92) |
AJRR (non-Truliant data) | 0.8 (0.78-0.83) | 1.73 (1.69-1.77) | 0.57 (0.55-0.59) | 1.2 (1.17-1.23) |
AOANJRR (all non-Truliant data)[13] | 1.2 (1.1-1.2) | 2.8 (2.7-2.9) | 0.9 (0.9-0.9) | 2.3 (2.3-2.4) |
UK NJR (all non-Truliant data)[14] | 0.48 (0.45-0.5) | 1.65 (1.6-1.7) | 0.38 (0.37-0.40) | 1.33 (1.30-1.36) |
- Citation: Jones K, Muehlmann AM, Musgrave M, Penrose CT. Short-term survivorship of Truliant® total knee arthroplasty implants utilizing the American Joint Replacement Registry. World J Orthop 2025; 16(7): 106281
- URL: https://www.wjgnet.com/2218-5836/full/v16/i7/106281.htm
- DOI: https://dx.doi.org/10.5312/wjo.v16.i7.106281